Type of first event and survival status by treatment group
| . | No pulses, N = 205, n (%) . | Pulses, N = 206, n (%) . |
|---|---|---|
| DFS status | ||
| CCR | 171 (83.4) | 187 (90.8) |
| Relapse | 32 (15.6) | 19 (9.2) |
| BM | 16 (7.8) | 10 (4.9) |
| CNS | 4 (2.0) | 1 (0.5) |
| Other isolated | 3 (1.5) | 2 (1.0) |
| BM + CNS | 5 (2.4) | 2 (1.0) |
| BM + other | 4 (2.0) | 4 (1.9) |
| Death without relapse | 2 (1.0) | 0 |
| Survival status | ||
| Alive | 188 (91.7) | 195 (94.7) |
| Dead | 17 (8.3) | 11 (5.3) |
| . | No pulses, N = 205, n (%) . | Pulses, N = 206, n (%) . |
|---|---|---|
| DFS status | ||
| CCR | 171 (83.4) | 187 (90.8) |
| Relapse | 32 (15.6) | 19 (9.2) |
| BM | 16 (7.8) | 10 (4.9) |
| CNS | 4 (2.0) | 1 (0.5) |
| Other isolated | 3 (1.5) | 2 (1.0) |
| BM + CNS | 5 (2.4) | 2 (1.0) |
| BM + other | 4 (2.0) | 4 (1.9) |
| Death without relapse | 2 (1.0) | 0 |
| Survival status | ||
| Alive | 188 (91.7) | 195 (94.7) |
| Dead | 17 (8.3) | 11 (5.3) |
DFS indicates disease-free survival; CCR, continuous complete remission; BM, bone marrow; and CNS, central nervous system.